The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More

The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
In a discovery that challenges the conventional understanding of semiconductor behavior, researchers at the University of California, Davis, have identified…
Read More
The evolution of artificial intelligence, particularly in the realm of natural language processing, has seen significant strides with the advent…
Read More
Terray Therapeutics, a burgeoning startup based in the Los Angeles area, has unveiled TerraBind, a groundbreaking potency prediction model designed…
Read More
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More
Next-generation sequencing (NGS) has fundamentally reshaped the landscape of genomics, providing scientists with an unprecedented capacity to rapidly and cost-effectively…
Read More
In a significant leap for the field of materials science, a team of researchers at New York University has unveiled…
Read More
In a significant development for AI-driven drug discovery, Terray Therapeutics, a Los Angeles-area startup, has introduced TerraBind, a novel potency…
Read More
Synthetic data, artificially created rather than sourced from real-world events, has emerged as a critical tool in the contemporary landscape…
Read More